JP4397233B2 - モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片 - Google Patents

モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片 Download PDF

Info

Publication number
JP4397233B2
JP4397233B2 JP2003522569A JP2003522569A JP4397233B2 JP 4397233 B2 JP4397233 B2 JP 4397233B2 JP 2003522569 A JP2003522569 A JP 2003522569A JP 2003522569 A JP2003522569 A JP 2003522569A JP 4397233 B2 JP4397233 B2 JP 4397233B2
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
seq
acid sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003522569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005507653A5 (https=
JP2005507653A (ja
Inventor
マーティン デニス
アメル ジョセ
アール ブロデュール バーナード
リウクス ステファン
クチュール ジュリー
Original Assignee
アイディー バイオメディカル コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイディー バイオメディカル コーポレイション filed Critical アイディー バイオメディカル コーポレイション
Publication of JP2005507653A publication Critical patent/JP2005507653A/ja
Publication of JP2005507653A5 publication Critical patent/JP2005507653A5/ja
Application granted granted Critical
Publication of JP4397233B2 publication Critical patent/JP4397233B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003522569A 2001-08-27 2002-08-27 モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片 Expired - Fee Related JP4397233B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31463401P 2001-08-27 2001-08-27
PCT/CA2002/001315 WO2003018052A1 (en) 2001-08-27 2002-08-27 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009175125A Division JP2009279003A (ja) 2001-08-27 2009-07-28 モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片

Publications (3)

Publication Number Publication Date
JP2005507653A JP2005507653A (ja) 2005-03-24
JP2005507653A5 JP2005507653A5 (https=) 2006-01-05
JP4397233B2 true JP4397233B2 (ja) 2010-01-13

Family

ID=23220768

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003522569A Expired - Fee Related JP4397233B2 (ja) 2001-08-27 2002-08-27 モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片
JP2009175125A Pending JP2009279003A (ja) 2001-08-27 2009-07-28 モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009175125A Pending JP2009279003A (ja) 2001-08-27 2009-07-28 モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片

Country Status (7)

Country Link
US (1) US7329500B2 (https=)
EP (1) EP1420817A1 (https=)
JP (2) JP4397233B2 (https=)
CN (1) CN1549727A (https=)
AU (1) AU2002325109C1 (https=)
CA (1) CA2457779A1 (https=)
WO (1) WO2003018052A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1149164A2 (en) 1999-01-22 2001-10-31 SmithKline Beecham Biologics SA Neisseria meningitidis polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9817824D0 (en) 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
US6632636B1 (en) * 1999-06-18 2003-10-14 Elitra Pharmaceuticals Inc. Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis
GB9921691D0 (en) 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Also Published As

Publication number Publication date
CN1549727A (zh) 2004-11-24
AU2002325109B2 (en) 2008-04-10
CA2457779A1 (en) 2003-03-06
US7329500B2 (en) 2008-02-12
WO2003018052A1 (en) 2003-03-06
JP2009279003A (ja) 2009-12-03
EP1420817A1 (en) 2004-05-26
JP2005507653A (ja) 2005-03-24
US20040242859A1 (en) 2004-12-02
WO2003018052A8 (en) 2003-08-21
AU2002325109C1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
JP4080876B2 (ja) ストレプトコッカス・ピオゲネス抗原及び対応するｄｎａフラグメント
JP2008289480A (ja) モラクセラ（ブランハメラ）カタラーリス抗原
JP4397233B2 (ja) モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片
US7393536B2 (en) Group B Streptococcus antigens and corresponding DNA fragments
US7410648B2 (en) Polypeptides of Moraxella (Branhamella) catarrhalis
US20080227706A1 (en) Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP1399563B1 (en) Moraxella (branhamella) catarrhalis antigens
AU2002302236A1 (en) Moraxella(Branhamella) catarrhalis antigens
JP2005514011A6 (ja) モラクセラ（ブランハメラ）カタルハリスのポリペプチド
AU2002325109A1 (en) Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
WO2004048575A2 (en) Streptococcus pneumoniae surface polypeptides
AU2002344869A1 (en) Moraxella (branhamella) catarrhalis antigens

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050826

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050902

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080924

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090123

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090223

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090729

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090915

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091013

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091020

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121030

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees